Marea Therapeutics

South San Francisco, United States · Founded 2024

Employees
11–50
Founded
2024
Business Model
B2B
Last Round
Series BJun 2024
Rounds
2

About

Marea Therapeutics is a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases. Incubated by Third Rock Ventures and launched in 2024, the company's lead program MAR001 is in Phase 2 clinical development for adults with metabolic dysfunction and high cardiovascular risk, while MAR002 is advancing toward the clinic for acromegaly. The company is headquartered in South San Francisco and led by a team of scientists and biopharma executives with deep expertise in cardioendocrine biology and human genetics.

Summary

Marea Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2024. Its most recent funding was a Series B round in Jun 2024. Investors include Sofinnova Investments, Forbion Capital Partners and Third Rock Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJun 2024

Sign up to see all 2 rounds

Series B through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Marea Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/marea-therapeutics"><img src="https://indexed.vc/api/badge/company/marea-therapeutics" alt="Marea Therapeutics on Indexed.vc" width="260" height="76" /></a>